Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide.
Based on the Albemarle Corporation stock forecasts from 13 analysts, the average analyst target price for Albemarle Corporation is USD 261.86 over the next 12 months. Albemarle Corporation’s average analyst rating is Hold . Stock Target Advisor’s own stock analysis of Albemarle Corporation is Slightly Bearish, which is based on 5 positive signals and 11 negative signals. At the last closing, Albemarle Corporation’s stock price was USD 243.15. Albemarle Corporation’s stock price has changed by +1.64% over the past week, +21.19% over the past month and +52.36% over the last year.
Abortion pills in Jeddah |+966572737505 | get cytotec
Albemarle Corporation (ALB) Stock Analysis Report
1. Page 1 of 10 Any information in this report is not , and should not be regarded as investment advice or as a recommendation regarding any particular security or course of
action. We recommend seeking a licensed professional for investment advice.
ALB:NYE (Albemarle Corporation)
Specialty Chemicals | NYE | Common Stock
Values as of 24th May, 2022
Stock Target Advisor
Detailed Stock Report
Report Date: 25th May, 2022
Last Close
USD 243.15
Change
+0.21(+0.09%)
Market Cap
USD 28.45B
1 Yr Capital Gain
53.87%
1 Yr Dividend Return
0.99%
1 Yr Total
Return
54.86%
Earning Growth (5 yr)
-80.79%
Average Target Price
261.86(+7.70% )
Average Analyst
Rating
Hold
Fundamental
Analysis
Slightly Bearish
Our view of the stock is Slightly Bearish with a score of 3.1 out of 10, where 0 is very bearish and 10 very bullish
What to like
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top
quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector.
Sometimes this is low because the company is not growing and has no growth potential.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What to not like
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering
to buy.
Poor return on equity
The company management has delivered below median return on equity in the most recent 4 quarters compared to its peers.
Poor return on assets
The company management has delivered below median return on assets in the most recent 4 quarters compared to its peers.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are
considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Low Revenue Growth
This stock has shown below median revenue growth in the previous 5 years compared to its sector
2. Page 2 of 10 Any information in this report is not , and should not be regarded as investment advice or as a recommendation regarding any particular security or course of
action. We recommend seeking a licensed professional for investment advice.
Low Dividend Growth
This stock has shown below median dividend growth in the previous 5 years compared to its sector.
3. Page 3 of 10 Any information in this report is not , and should not be regarded as investment advice or as a recommendation regarding any particular security or course of
action. We recommend seeking a licensed professional for investment advice.
ALB:NYE (Albemarle Corporation)
Specialty Chemicals | | Common Stock
Stock Target Advisor
Detailed Stock Report
Report Date: 25th May, 2022
Adjusted Closing Share Volume
Relative Returns Relative Performance (Total Returns)
Security Capital Gain Dividend Return Total Return
ALB
Albemarle Corporation
+52.4% +1% +53.3%
VTI
Vanguard Index Funds -
Vanguard Total Stock Market
ETF
-9.4% +1.4% -8.1%
Company Overview
Albemarle Corporation develops, manufactures, and markets engineered specialty chemicals worldwide. It operates through three
segments: Lithium, Bromine, and Catalysts. The Lithium segment offers lithium compounds, including lithium carbonate, lithium hydroxide,
lithium chloride, and lithium specialties; and reagents, such as butyllithium and lithium aluminum hydride for use in lithium batteries for
consumer electronics and electric vehicles, high performance greases, thermoplastic elastomers for car tires, rubber soles, plastic bottles,
catalysts for chemical reactions, organic synthesis processes in the areas of steroid chemistry and vitamins, life sciences, pharmaceutical
industry, and other markets. It also provides cesium products for the chemical and pharmaceutical industries; zirconium, barium, and
titanium products for pyrotechnical applications that include airbag initiators; technical services for the handling and use of reactive lithium
products; and lithium-containing by-products recycling services. The Bromine segment offers bromine and bromine-based fire safety
solutions; specialty chemicals, including elemental bromine, alkyl and inorganic bromides, brominated powdered activated carbon, and
other bromine fine chemicals for use in chemical synthesis, oil and gas well drilling and completion fluids, mercury control, water
purification, beef and poultry processing, and other industrial applications; and other specialty chemicals, such as tertiary amines for
surfactants, biocides, and disinfectants and sanitizers. The Catalysts segment provides hydroprocessing, isomerization, and akylation
catalysts; fluidized catalytic cracking catalysts and additives; and organometallics and curatives. The company serves the energy storage,
petroleum refining, consumer electronics, construction, automotive, lubricants, pharmaceuticals, and crop protection markets. Albemarle
Corporation was founded in 1887 and is headquartered in Charlotte, North Carolina. Address: 4250 Congress Street, Charlotte, NC, United
States, 28209
4. Page 4 of 10 Any information in this report is not , and should not be regarded as investment advice or as a recommendation regarding any particular security or course of
action. We recommend seeking a licensed professional for investment advice.
Company Website
https://www.albemarle.com
Address
4250 Congress Street, Charlotte, NC, United States, 28209
Fiscal Year End
December
Employees
6000
Technical Indicators
Value Value
Beta 1.55 52 Week High 290.40
Short Ratio 1.63 52 Week Low 156.98
Shorted Shares 1,493,545 200 Day Moving Average 227.02
Shorted Shares Previous Month 1,501,663 50 Day Moving Average 211.38
Shares Held By Insiders 33.60% Short Percentage 2.00%
Shares Held by Institutions 83.12 Dividend Yield 0.67%
5. Page 5 of 10 Any information in this report is not , and should not be regarded as investment advice or as a recommendation regarding any particular security or course of
action. We recommend seeking a licensed professional for investment advice.
ALB:NYE (Albemarle Corporation)
Specialty Chemicals | | Common Stock
Stock Target Advisor
Detailed Stock Report
Report Date: 25th May, 2022
Market Performance
Market Performance vs. Industry / Classification (Specialty Chemicals) Market Performance vs. Exchange (Nasdaq Global Select)
Value Sector Median
Percentile
Rank
Grade Market Median Percentile Rank Grade
YTD
Capital Gain 4.01% -16.1% 79% -13.3% 86%
Dividend Return 0.17% 0.4% 7% 1.0% 8%
Total Return 4.18% -14.7% 79% -12.4% 85%
Trailing 12 Months
Capital Gain 53.87% -9.2% 93% -11.0% 95%
Dividend Return 0.99% 1.4% 32% 2.8% 18%
Total Return 54.86% -7.0% 93% -8.2% 95%
Trailing 5 Years
Capital Gain 115.96% 3.3% 100% 5.3% 90%
Dividend Return 6.45% 7.9% 33% 12.8% 20%
Total Return 122.41% 13.5% 100% 20.9% 89%
Average Annual (5 Year Horizon)
Capital Gain 30.93% 9.8% 86% 4.8% 89%
Dividend Return 1.60% 1.6% 48% 2.1% 38%
Total Return 32.53% 12.0% 86% 8.0% 89%
Risk Return Profile
Volatility (Standard
Deviation)
65.64% 34.6% 20% 22.8% 12%
Risk Adjusted Return 49.56% N/A 73% 40.2% 61%
Market Capitalization 28.45B 3.58B 84% 1.11B 91%
6. Page 6 of 10 Any information in this report is not , and should not be regarded as investment advice or as a recommendation regarding any particular security or course of
action. We recommend seeking a licensed professional for investment advice.
Key Financial Ratios
Ratios vs. Industry / Classification (Computer Hardware) Ratios vs. Exchange (Nasdaq Global Select)
Value Sector Median
Percentile
Rank
Grade Market Median Percentile Rank Grade
Market Value
peratio 101.6 23.7 9% 16.1 6%
pbratio 4.7 2.2 14% 1.6 16%
pcfratio 82.6 15.2 7% 7.1 4%
pfcfratio 48.3 11.4 2% 10.9 6%
Management Effectiveness
retequity 6.07% 13.0% 28% 10.0% 37%
retinvcap 9.70% 9.7% 51% 5.5% 66%
retass 4.37% 5.0% 40% 2.5% 68%
debtequityratio 35.63% 75.7% 83% 68.5% 70%
Technical Ratios
yield 0.67% 1.6% 13% 3.1% 9%
sratio 1.63 2.77 76% 2.12 58%
spercent 1.45% 2.0% 62% 3.6% 71%
beta 1.55 1.27 24% 1.03 18%
7. Page 7 of 10 Any information in this report is not , and should not be regarded as investment advice or as a recommendation regarding any particular security or course of
action. We recommend seeking a licensed professional for investment advice.
ALB:NYE (Albemarle Corporation)
Specialty Chemicals | | Common Stock
Stock Target Advisor
Detailed Stock Report
Report Date: 25th May, 2022
Recent Analyst Ratings
Price Action Rating Action Analyst Rating Price date
Maintains RBC Royalbank Outperform USD 300 » USD 314 2022-05-24
Maintains Deutsche Bank Capital Buy USD 290 » USD 320 2022-05-24
Maintains Wells Fargo Overweight USD 285 » USD 320 2022-05-24
Maintains KeyBanc Underweight USD 215 » USD 217 2022-05-24
Upgraded by Wells Fargo
Equal Weight »
Overweight
2022-05-11
Target Raised by RBC Royalbank USD 276 » USD 300 2022-05-10
Target Raised by Cowen USD 275 » USD 300 2022-05-06
Target Raised by Deutsche Bank Capital USD 250 » USD 290 2022-05-06
Target Raised by Oppenheimer Holdings USD 307 » USD 368 2022-05-06
Target Raised by Citigroup USD 262 » USD 279 2022-05-06
Target Raised by Mizuho Securities USD 243 » USD 293 2022-05-06
Target Raised by KeyBanc USD 163 » USD 198 2022-04-05
Target Lowered by Robert W Baird USD 245 » USD 228 2022-02-22
Target Lowered by RBC Royalbank Outperform USD 290 » USD 270 2022-02-22
Target Lowered by Bank of America Securities USD 230 » USD 216 2022-02-19
Target Lowered by BMO Financial USD 300 » USD 280 2022-02-18
Maintains Mizuho Securities Neutral USD 281 » USD 243 2022-02-18
Target Lowered by Citigroup USD 280 » USD 244 2022-02-18
Maintains KeyBanc Underweight USD 153 » USD 163 2022-02-18
Upgraded by Bank of America Securities Underperform » Neutral 2022-02-01
Upgrades HSBC Buy USD 250 » USD 280 2022-01-27
Target Lowered by Citigroup USD 323 » USD 280 2022-01-11
Maintains KeyBanc Underweight USD 144 » USD 153 2022-01-10
Downgraded by Goldman Sachs Neutral » Sell USD 199 » USD 205 2021-12-15
Reiterated by Evercore ISI Buy USD 295 2021-11-21
8. Page 8 of 10 Any information in this report is not , and should not be regarded as investment advice or as a recommendation regarding any particular security or course of
action. We recommend seeking a licensed professional for investment advice.
ALB:NYE (Albemarle Corporation)
Specialty Chemicals | | Common Stock
Stock Target Advisor
Detailed Stock Report
Report Date: 25th May, 2022
Annual Financial (USD)
9. Page 9 of 10 Any information in this report is not , and should not be regarded as investment advice or as a recommendation regarding any particular security or course of
action. We recommend seeking a licensed professional for investment advice.
ALB:NYE (Albemarle Corporation)
Specialty Chemicals | | Common Stock
Stock Target Advisor
Detailed Stock Report
Report Date: 25th May, 2022
Quarterly Financial (USD)
10. Page 10 of 10 Any information in this report is not , and should not be regarded as investment advice or as a recommendation regarding any particular security or course of
action. We recommend seeking a licensed professional for investment advice.
ALB:NYE (Albemarle Corporation)
Specialty Chemicals | | Common Stock
Stock Target Advisor
Detailed Stock Report
Report Date: 25th May, 2022
Largest Industry Peers for Specialty Chemicals
Symbol Company Name Price(Change) Market Cap
LIN Linde plc +0.07 (+0.0%) USD 158.45B
SHW The Sherwin-Williams Company -1.62 (-0.6%) USD 67.10B
APD Air Products and Chemicals Inc -1.13 (-0.5%) USD 52.77B
ECL Ecolab Inc -2.63 (-1.6%) USD 45.56B
LYB LyondellBasell Industries N.V -0.27 (-0.3%) USD 35.34B
IFF International Flavors & Fragra.. -0.57 (-0.4%) USD 32.86B
DD DuPont de Nemours Inc -0.83 (-1.3%) USD 32.47B
PPG PPG Industries Inc -1.35 (-1.1%) USD 28.27B
AVTR Avantor Inc -0.13 (-0.4%) USD 19.24B
WLK Westlake Chemical Corporation -1.68 (-1.3%) USD 16.20B
ETFs Containing ALB
Symbol Company Name Weight Mer Price(Change) Market Cap
FTC First Trust Large Cap Growth A.. 0.00 % 0.61 % -0.75 (0.0%) USD 0.91B
GNRX VanEck Vectors Generic Drugs E.. 0.00 % 0.55 % N/A USD 3.35M
IYM iShares U.S. Basic Materials E.. 0.00 % 0.00 % -1.16 (0.0%) USD 1.13B
LIT Global X Funds - Global X Lith.. 0.00 % 0.75 % -1.55 (0.0%) USD 4.26B
NOBL 0.00 % 0.35 % N/A N/A
PYZ Invesco DWA Basic Materials Mo.. 0.00 % 0.60 % -1.29 (0.0%) USD 0.19B
QCLN First Trust NASDAQ Clean Edge .. 0.00 % 0.60 % -1.77 (0.0%) USD 1.91B
XT iShares Exponential Technologi.. 0.00 % 0.47 % -1.12 (0.0%) USD 3.29B
MID American Century Mid Cap Growt.. 0.00 % 0.00 % -1.28 (0.0%) N/A
VCAR Simplify Volt RoboCar Disrupti.. 0.00 % 0.00 % -0.17 (0.0%) N/A
The Stock Target Advisor platform run millions of calculations every day on over 30,000 Canadian and American stocks, comparing and
ranking their financial and market performance against their sectors and exchange.
We represent the percentile ranking using the following grading system.
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%